4.4 Article

Shortening of the QT Interval is Observed Soon after Sleeve Gastrectomy in Morbidly Obese Patients

Journal

OBESITY SURGERY
Volume 24, Issue 1, Pages 167-170

Publisher

SPRINGER
DOI: 10.1007/s11695-013-1128-3

Keywords

Sleeve gastrectomy; QT interval; Sudden cardiac death

Categories

Ask authors/readers for more resources

Morbidly obese patients have an increased risk of sudden cardiac death. It is well known that obesity prolongs the QT interval, which in turn may cause ventricular arrhythmia and sudden cardiac death. The objective of this study was to establish whether sleeve gastrectomy shortens the QT interval. Twenty-eight consecutive patients underwent sleeve gastrectomy at our institution between September 2010 and March 2011 and were included in the study. The indications for bariatric surgery were in accordance with French national guidelines. For each patient, an electrocardiogram was recorded before and then 3 months after surgery. The corrected QT (QTc) was determined independently by two physicians. The mean body mass index was 45.27 +/- 6.09 kg/m(2) before surgery and 38.32 +/- 5.19 kg/m(2) 3 months after surgery. The mean weight loss over this period was 20.71 +/- 7.57 kg. The QTc interval was 427 +/- 18.6 ms (415.7 +/- 12.06 in men and 428.4 +/- 18.96 in women) prior to surgery and was significantly lower 3 months after surgery (398.6 +/- 15.5 ms overall, 391.3 +/- 7.63 in men, and 399.6 +/- 16.02 in women). The QTc interval decreased in all individual patients (by an average of 28.5 +/- 15.6 ms overall, 24.3 +/- 8.38 in men, and 29 +/- 16.23 in women). Weight loss and decreased QTc interval were not significantly correlated (p = 0.88). Sleeve gastrectomy in morbidly obese patients was associated with a significantly lower QTc interval 3 months after surgery. These findings imply that bariatric surgery might reduce the risk of sudden cardiac death in this patient population.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Endocrinology & Metabolism

Pharmacodynamics and pharmacokinetics of extended-release metformin in patients with type 2 diabetes and chronic kidney disease stage 3B

Jean-Daniel Lalau, Youssef Bennis, Abdallah Al-Salameh, Anne-Sophie Hurtel-Lemaire, Salha Fendri

DIABETES OBESITY & METABOLISM (2022)

Review Endocrinology & Metabolism

Protection by metformin against severe Covid-19: An in-depth mechanistic analysis

Nicolas Wiernsperger, Abdallah Al-Salameh, Bertrand Cariou, Jean-Daniel Lalau

Summary: Since the outbreak of Covid-19, studies have shown a favorable association between metformin and Covid-19 outcomes in patients with type 2 diabetes mellitus. Metformin can alleviate cytokine storm, reduce virus entry into cells, protect microvessels, and prevent secondary fibrosis. The findings suggest that metformin is a unique drug with multiple mechanisms of action against Covid-19.

DIABETES & METABOLISM (2022)

Article Endocrinology & Metabolism

Screening for sleep-disordered breathing in people with type 1 diabetes by combining polysomnography with glucose variability assessment

Damien Basille, Marine Timmerman, Aurelie Basille-Fantinato, Abdallah Al-Salameh, Salha Fendri, Jean-Daniel Lalau

Summary: This study aimed to investigate the prevalence of sleep-disordered breathing (SDB) in type 1 diabetes (T1DM) patients. The results showed that SDB was highly prevalent in these patients and was associated with obesity. However, there was no association between sleep disorders and high glucose variability or low glucose levels.

DIABETES RESEARCH AND CLINICAL PRACTICE (2022)

Article Endocrinology & Metabolism

Impact of diabetes on COVID-19 prognosis beyond comorbidity burden: the CORONADO initiative

Bertrand Cariou, Matthieu Wargny, Anne-Sophie Boureau, Sarra Smati, Blandine Tramunt, Rachel Desailloud, Maylis Lebeault, Coralie Amadou, Deborah Ancelle, Beverley Balkau, Lyse Bordier, Sophie Borot, Muriel Bourgeon, Olivier Bourron, Emmanuel Cosson, Martin Eisinger, Celine Gonfroy-Leymarie, Jean-Baptiste Julla, Lucien Marchand, Laurent Meyer, Dominique Seret-Begue, Dominique Simon, Ariane Sultan, Charles Thivolet, Anne Vambergue, Camille Vatier, Patrice Winiszewski, Pierre-Jean Saulnier, Bernard Bauduceau, Pierre Gourdy, Samy Hadjadj

Summary: This study aims to investigate whether diabetes is a risk factor for COVID-19, independent of age and comorbidities.

DIABETOLOGIA (2022)

Review Endocrinology & Metabolism

Diabetes and cardiovascular risk according to sex: An overview of epidemiological data from the early Framingham reports to the cardiovascular outcomes trials

Abdallah Al-Salameh, Nacera El Bouzegaoui, Marie Saraval-Gross

Summary: Male sex is a significant cardiovascular risk factor, and men have a higher prevalence of cardiovascular disease than women. Diabetes affects cardiovascular risk differently between men and women, with women having a greater relative risk of cardiovascular events. The impact of anti-hyperglycemic drugs on cardiovascular outcomes according to sex is not well known. Cardiovascular outcomes trials provide an opportunity to study the effects of novel anti-hyperglycemic drugs on cardiovascular outcomes in men and women with type-2 diabetes.

ANNALES D ENDOCRINOLOGIE (2023)

Article Endocrinology & Metabolism

Smoking and diabetes interplay: A comprehensive review and joint statement

Vincent Durlach, Bruno Verges, Abdallah Al-Salameh, Thibault Bahougne, Farid Benzerouk, Ivan Berlin, Carole Clair, Jacques Mansourati, Alexia Rouland, Daniel Thomas, Philippe Thuillier, Blandine Tramunt, Anne-Laurence Le Faou

Summary: Evidence shows that smoking increases the risk of pre-diabetes and diabetes in the general population and aggravates chronic diabetic complications and glycemic control in individuals with diabetes. A joint position statement by the French-Speaking Society on Tobacco and the French-Speaking Society of Diabetes summarizes the data on the association between smoking and diabetes, as well as the impact of smoking and smoking cessation on individuals with type 1, type 2, and gestational diabetes mellitus. It also provides evidence-based information on pharmacological and behavioral strategies for smoking cessation in these patients.

DIABETES & METABOLISM (2022)

Article Endocrinology & Metabolism

Pituitary apoplexy in the aftermath of a SARS-CoV-2 infection: a case series from Amiens University Hospital

Joe Balmain, Meshal Jarebi, Abdallah Al-Salameh, Patrick Toussaint, Marine Timmerman, Louis Chenin, Jean-Marc Constans, Rachel Desailloud

Summary: This case series provides support for the association between SARS-CoV-2 infection and pituitary apoplexy. The findings emphasize the importance of being aware of potential pituitary diseases caused by the virus.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2022)

Letter Endocrinology & Metabolism

Pituitary apoplexy and SARS-CoV-2 infection: we need to look beyond the acute phase

Abdallah Al-Salameh, Joe Balmain, Rachel Desailloud

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2022)

Article Nutrition & Dietetics

Perigestational exposure of a combination of a high-fat diet and pesticide impacts the metabolic and microbiotic status of dams and pups; a preventive strategy based on prebiotics

Narimane Djekkoun, Flore Depeint, Marion Guibourdenche, Hiba El Khayat Et Sabbouri, Aurelie Corona, Larbi Rhazi, Jerome Gay-Queheillard, Leila Rouabah, Maurice Biendo, Abdallah Al-Salameh, Jean-Daniel Lalau, Veronique Bach, Hafida Khorsi-Cauet

Summary: This study evaluated the effects of perigestational exposure to a high-fat diet and chlorpyrifos on glycemia, lipid profiles, and microbial populations in rats and their offspring, and tested the preventive strategy of inulin supplementation. The results demonstrated that exposure to a high-fat diet and co-exposure to a high-fat diet and chlorpyrifos induced dysmetabolism and an imbalance in the gut flora, which could be mitigated by inulin supplementation.

EUROPEAN JOURNAL OF NUTRITION (2023)

Article Biology

Thyrotropin Levels in Patients with Coronavirus Disease 2019: Assessment during Hospitalization and in the Medium Term after Discharge

Abdallah Al-Salameh, Noemie Scherman, Imane Adda, Juliette Andre, Yoann Zerbib, Julien Maizel, Jean-Daniel Lalau, Etienne Brochot, Claire Andrejak, Rachel Desailloud

Summary: This study compared TSH levels in hospitalized COVID-19 patients with critical and non-critical conditions, and described the status of TSH levels three months after hospitalization. The findings suggest that COVID-19 is associated with transient suppression of TSH in some patients, and higher TSH levels three months after COVID-19 may indicate recovery from non-thyroidal illness syndrome.

LIFE-BASEL (2022)

Article Environmental Sciences

Does prenatal exposure to multiple airborne and tap-water pollutants increase neonatal thyroid-stimulating hormone concentrations? Data from the Picardy region, France

Sylvain Chamot, Abdallah Al-Salameh, Pascal Petit, Vincent Bonneterre, Christophe Cance, Guillaume Decocq, Agnes Boullier, Karine Braun, Rachel Desailloud

Summary: Systematic screening for congenital hypothyroidism in Picardy, France revealed unexpected heterogeneity in the geographic distribution of newborn thyroid-stimulating hormone concentrations, potentially related to environmental pollutants.

SCIENCE OF THE TOTAL ENVIRONMENT (2023)

No Data Available